Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer

Human Pathology

Volumn 46, Issue 2, 2015, Pages 295-303

  Wan, Yueping ^a   Zeng, Zhao Chang ^a   Xi, Ming ^a   Wan, Song ^a   Hua, Wei ^a   Liu, Yuan Ling ^a   Zhou, Yu Lin ^a   Luo, Hong Wei ^a   Jiang, Fu Neng ^b   Zhong, Wei De ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Apelin; Biochemical recurrence free survival; Clinicopathological characteristic; MicroRNA 224; Prostate cancer

Indexed keywords

APELIN; MICRORNA; MICRORNA 224; UNCLASSIFIED DRUG; APLN PROTEIN, HUMAN; MIRN224 MICRORNA, HUMAN; PROSTATE SPECIFIC ANTIGEN; SIGNAL PEPTIDE; TUMOR MARKER;

AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL MIGRATION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; TUMOR INVASION; UPREGULATION; VERY ELDERLY; ADULT; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84920941755     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.10.027     Document Type: Article

References (35)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer Statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 2010 765 781
3. J. Molitierno, A. Evans, J.L. Mohler, E. Wallen, D. Moore, and R.S. Pruthi Characterization of biochemical recurrence after radical prostatectomy Urol Int 77 2006 130 134
4. L. Klotz Hormone therapy for patients with prostate carcinoma Cancer 88 2000 3009 3014
5. M.A. Eisenberger, B.A. Blumenstein, and E.D. Crawford Bilateral orchiectomy with or without flutamide for metastatic prostate cancer N Engl J Med 339 1998 1036 1042
6. S. Yamamoto, S. Kawakami, and J. Yonese Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy Jpn J Clin Oncol 42 2012 541 547
7. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
8. I. Bentwich, A. Avniel, Y. Karov, R. Aharonov, S. Gilad, and O. Barad Identification of hundreds of conserved and nonconserved human microRNAs Nat Genet 37 2005 766 770
9. J. Chou, P. Shahi, and Z. Werb microRNA-mediated regulation of the tumor microenvironent Cell Cycle 12 2013 3262 3271
10. G.A. Calin, C.G. Liu, and C. Sevignani MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias Proc Natl Acad Sci U S A 101 2004 11755 11760
11. K.P. Porkka, M.J. Pfeiffer, K.K. Waltering, R.L. Vessella, T.L. Tammela, and T. Visakorpi MicroRNA expression profiling in prostate cancer Cancer Res 67 2007 6130 6135
12. H.C. He, Z.D. Han, and Q.S. Dai Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients BMC Genomics 14 2013 757
13. Z.Y. Lin, Y.Q. Huang, and Y.Q. Zhang MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 Int J Cancer 135 2014 541 550
14. B.S. Taylor, N. Schultz, and H. Hieronymus Integrative genomic profiling of human prostate cancer Cancer Cell 18 2010 11 22
15. A. Krek, D. Grun, and M.N. Poy Combinatorial microRNA target predictions Nat Genet 37 2005 495 500
16. D. Betel, M. Wilson, A. Gabow, D.S. Marks, and C. Sander The microRNA.org resource: targets and expression Nucleic Acids Res 36 2008 D149 D153
17. T.W. Ke, H.L. Hsu, Y.H. Wu, W.T. Chen, Y.W. Cheng, and C.W. Cheng MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42 Dis Markers 2014 2014 617150
18. Y. Wang, and C.G. Lee Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? Epigenomics 3 2011 235 243
19. S.T. Mees, W.A. Mardin, and S. Sielker Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas Ann Surg Oncol 16 2009 2339 2350
20. H. Liu, A.R. Brannon, A.R. Reddy, G. Alexe, M.W. Seiler, and A. Arreola Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell renal cell carcinoma BMC Syst Biol 4 2010 51
21. M.N. Nikiforova, G.C. Tseng, D. Steward, D. Diorio, and Y.E. Nikiforov MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility J Clin Endocrinol Metab 93 2008 1600 1608
22. Y. Ladeiro, G. Couchy, and C. Balabaud MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations Hepatology 47 2008 1955 1963
23. Q. Li, G. Wang, and J.L. Shan MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion J Gastroenterol Hepatol 25 2010 164 171
24. Y. Wang, A.T. Lee, and J.Z. Ma Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target J Biol Chem 283 2008 13205 13215
25. Y.X. Wang, X.Y. Zhang, B.F. Zhang, C.Q. Yang, X.M. Chen, and H.J. Gao Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis J Dig Dis 11 2010 50 54
26. Z. Li, J. Lu, M. Sun, S. Mi, H. Zhang, and R.T. Luo Distinct microRNA expression profiles in acute myeloid leukemia with common translocations Proc Natl Acad Sci USA 105 2008 15535 15540
27. E.S. Martens-Uzunova, S.E. Jalava, N.F. Dits, G.J. van Leenders, S. Moller, and J. Trapman Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer Oncogene 31 2012 978 991
28. N.M. White, T.F. Chow, and S. Mejia-Guerrero Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer Br J Cancer 102 2010 1244 1253
29. R.L. Prueitt, M. Yi, and R.S. Hudson Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer Prostate 68 2008 1152 1164
30. A.D. Hofmann, F. Friedmacher, H. Takahashi, M. Hunziker, J.H. Gosemann, and P. Puri Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia Pediatr Surg Int 30 2014 197 203
31. M. Wang, R.C. Gupta, and S. Rastogi Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure J Card Fail 19 2013 509 516
32. W. Wang, S.M. McKinnie, and V.B. Patel Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues J Am Heart Assoc 2 2013 e000249
33. Z. Wang, G.H. Greeley Jr., and S. Qiu Immunohistochemical localization of apelin in human normal breast and breast carcinoma J Mol Histol 39 2008 121 124
34. J. Berta, I. Kenessey, and J. Dobos Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis J Thorac Oncol 5 2010 1120 1129
35. F.X. Picault, C. Chaves-Almagro, F. Projetti, H. Prats, B. Masri, and Y. Audigier Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas Eur J Cancer 50 2014 663 674